These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22970613)

  • 1. [Update on current care guidelines: psoriasis and psoriatic arthritis].
    Duodecim; 2012; 128(15):1620-1. PubMed ID: 22970613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Current Care Guideline: Psoriasis (skin and joints).
    Duodecim; 2017; 133(11):1107-8. PubMed ID: 29243903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
    Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
    Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective new biologic therapies for psoriasis and psoriatic arthritis.
    Mortel MR; Emer J
    J Drugs Dermatol; 2010 Aug; 9(8):947-58. PubMed ID: 20684145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin and bone: the pathogenetic relationship between psoriasis and psoriatic arthritis.
    Ko JM; Qureshi AW
    G Ital Dermatol Venereol; 2010 Jun; 145(3):393-406. PubMed ID: 20461047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
    Channual J; Wu JJ; Dann FJ
    Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis in patients with psoriasis.
    Gulliver W
    Br J Dermatol; 2008 Aug; 159 Suppl 2():2-9. PubMed ID: 18700909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteomyelitis occurring during infliximab treatment of severe psoriasis.
    Sri JC; Tsai CL; Deng A; Gaspari AA
    J Drugs Dermatol; 2007 Feb; 6(2):207-10. PubMed ID: 17373180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities in patients with psoriasis.
    Gottlieb AB; Dann F
    Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRAPPA 2013 basic/translational/clinical science update: comorbidity monitoring.
    Boehncke WH
    J Rheumatol; 2014 Jun; 41(6):1224-6. PubMed ID: 24882857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study.
    Montaudié H; Albert-Sabonnadière C; Acquacalda E; Fontas E; Danré A; Roux C; Ortonne JP; Lacour JP; Euller-Ziegler L; Passeron T
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1186-91. PubMed ID: 23981008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry.
    Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities?
    Lotti T; Hercogova J; Prignano F
    Dermatol Ther; 2010; 23(2):119-22. PubMed ID: 20415818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patients with psoriasis have an increased risk of cardiovascular diseases].
    Ahlehoff O; Gislason G; Lindhardsen J; Skov L; Hansen PR
    Ugeskr Laeger; 2012 May; 174(21):1450-2. PubMed ID: 22640784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M; Lebwohl M
    Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis.
    Stiff KM; Glines KR; Porter CL; Cline A; Feldman SR
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1209-1218. PubMed ID: 30449211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative management of medications for psoriasis and psoriatic arthritis: a review for the dermasurgeon.
    Hernandez C; Emer J; Robinson JK
    Dermatol Surg; 2008 Apr; 34(4):446-59. PubMed ID: 18248470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriatic disease--from skin to bone.
    Ritchlin C
    Nat Clin Pract Rheumatol; 2007 Dec; 3(12):698-706. PubMed ID: 18037929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.